AVANIR Pharmaceuticals (AVNR)
Create an Alert
4.44
-0.17 -3.79%
NASDAQ
Jun 19, 5:00PM
BATS Real time
Currency in USD
AVANIR Pharmaceuticals Shareholders Equity:
32.09M for March 31, 2013AVANIR Pharmaceuticals Historical Shareholders Equity Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 32.09M |
| Dec. 31, 2012 | 26.19M |
| Sept. 30, 2012 | 36.84M |
| June 30, 2012 | 47.09M |
| March 31, 2012 | 59.36M |
| Dec. 31, 2011 | 67.86M |
| Sept. 30, 2011 | 71.34M |
| June 30, 2011 | 85.02M |
| March 31, 2011 | 96.72M |
| Dec. 31, 2010 | 110.06M |
| Sept. 30, 2010 | 28.01M |
| June 30, 2010 | 31.47M |
| March 31, 2010 | 10.03M |
| Dec. 31, 2009 | 16.00M |
| Sept. 30, 2009 | 19.94M |
| June 30, 2009 | 15.18M |
| March 31, 2009 | 19.74M |
| Dec. 31, 2008 | 24.21M |
| Sept. 30, 2008 | 29.00M |
| June 30, 2008 | 33.85M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Shareholders' Equity
Shareholders' equity is difference between a company's total assets and total liabilities. Also referred to as stockholders' equity, net worth, or net assets.
Learn More
AVNR Shareholders Equity Benchmarks
| Companies | |
|---|---|
| Catalyst Pharmaceutical Partners | 14.62M |
| Galectin Therapeutics | -1.036M |
| Valeant Pharmaceuticals International | 3.587B |
AVNR Shareholders Equity Rankings
| Overall |
62nd percentile 6303 of 16782 |
| Sector |
66th percentile 472 of 1410 in Healthcare |
| Industry |
63rd percentile 56 of 152 in Drug Manufacturers - Specialty & Generic |
AVNR Shareholders Equity Range, Past 5 Years
| Minimum | 10.03M | Mar 2010 |
| Maximum | 110.06M | Dec 2010 |
| Average | 43.00M |
